Darvadstrocel
Darvadstrocel, sold under the brand name Alofisel, is a medication to treat complex perianal fistulas in adults with non-active/mildly active luminal Crohn's disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy. It contains stem cells from the fat tissue of adult donors. It is injected into the fistula tract tissue.

It was approved for use in the European Union in March 2018.
Q497
perianal
Concept
Q189470
fistula
Concept
Q1472
Crohn's disease
Concept
Q189470
fistula
Concept
Q48196
stem cell
Concept
Q96375967
Darvadstrocel
UNK
2018-03-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
March 2018
DATE
symptoms and signs
symptoms and signs